aTyr Pharma, Inc. (ATYR)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$0.3050−$0.0326 (−9.66%) on the dayAs of the close; data may be delayed.
ATYR price, last 12 months
Key stats
- Previous close
- $0.3376
- Open
- $0.3093
- Day range
- $0.2820 – $0.3166
- 52-week range
- $0.2820 – $1.12
- Volume
- 8.4M
- Avg volume (20 days)
- 7.8M
- Market cap
- $29.9M
Performance
1W−16.0%
1M−44.7%
3M−42.2%
6M−61.5%
YTD−61.1%
1Y−67.9%
vs S&P 500, 1Y−84.7 pts
Technicals and fundamentals
About aTyr Pharma, Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $29.9M